Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics
AKTX•Strategic research collaboration with Whitehawk Therapeutics
July 21 (Reuters) - Akari Therapeutics PLC AKTX.O:
- Akari Therapeutics enters strategic research collaboration with Whitehawk Therapeutics
- Akari Therapeutics and Whitehawk to conduct preclinical studies of PH1 payload with TOP1i ADC platform
- Collaboration to commence immediately with interim data updates anticipated
